article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

In 2006, the first research paper by Johns Hopkins was published on the positive long-term impact of using psilocybin in a therapeutic study. While decriminalization decreases the negative impact of legal issues, it does not provide accessible, safe, and regulated psilocybin for those seeking treatment. Minnesota Rep. Missouri Rep.

article thumbnail

Little Green Pharma Seals Italian Medical Cannabis Deal

Cannabis Law Report

Italian doctors have been able to prescribe cannabis-based medicines since 2006, but the process is heavy on red-tape. Access to these imported medicines has been hampered by not only red tape, but also the pandemic.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why we haven’t cured cancer

Otherside Farms

Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma (full – 2006). 9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer through Cdc2 Regulation (full – 2006). abst – 2006). 2006] – PubMed result. abst – 2004).

article thumbnail

Metrc Grab Rhode Island Contract

Cannabis Law Report

And this same tracking information is accessible to state regulators, providing the ultimate transparency to ensure regulatory compliance, help combat the illicit market, and safeguard the health and well-being of Rhode Island medical marijuana patients. Rhode Island was an early adopter of medical marijuana, legalizing the program in 2006.

Data 52
article thumbnail

Harborside Inc. Announces Stock Option Grants

Cannabis Law Report

Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of California consumers. For the latest news, activities, and media coverage, please visit the Harborside corporate website at www.investharborside.com or connect with us on LinkedIn , About Harborside: Harborside Inc.

article thumbnail

Policy Analysis Paper: Medicinal cannabis and driving: the intersection of health and road safety policy

Cannabis Law Report

Recent shifting attitudes towards the medical use of cannabis has seen legal access pathways established in many jurisdictions in North America, Europe and Australasia. Others who need to drive are excluded from accessing a needed medication and associated therapeutic benefit. Background. Conclusion. S0955395921002127-main.

Policy 66
article thumbnail

Australia – Policy Analysis: Medicinal cannabis and driving: the intersection of health and road safety policy – “there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications”

Cannabis Law Report

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects. Faculty of Science, School of Psychology, The University of Sydney, Sydney, NSW 2006, Australia.